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Abstract 
 
Malignant mesothelioma is a rare type of tumor that carries poor prognosis, being the life 
expectancy generally less than one year after diagnosis. Mesothelioma affects primarily the 
mesothelium that covers the lungs, but it can also affect the heart, abdomen and other organs. The 
most common approach to the cytoreduction of the primary tumor is surgery, but the majority of 
mesothelioma patients cannot tolerate it. Ablative procedures, such as the ones that use 
radiofrequency or ultrasound waves, become an attractive approach since they are much less 
invasive. In both cases, ablation is achieved by increasing the tissue temperature to over 60ºC, 
leading to cell death almost instantly. In the first case, however, the heat generated from a high 
frequency alternating current is used to ablate the damaged tissue, while in the second case the heat 
source is an ultrasound beam focused through a transducer completely external to the patient.  
The objective of this study was to determine and to compare the feasibility of 
transcutaneous and percutaneous mesothelioma debulking with Magnetic Resonance guided 
Focused Ultrasound Surgery (MRgFUS) and Radiofrequency Ablation (RFA), respectively, in a 
porcine model of mesothelioma. The tumor model was developed through the injection of a human 
mesothelioma cell line (MSTO-211H) in the right lower hemithorax of 13 Yorkshire pigs. Pigs 
were imaged using Magnetic Resonance Imaging (MRI) every 4 weeks post-inoculation. In T2-
wighted MRI pulse sequences, signs of pleural effusion, presence of adhesions and an increase in 
diaphragm thickness were observed in several animals, then confirmed during post-treatment 
necropsy procedure.  
Five pigs were treated with RFA (guided by fluoroscopy imaging), while other four animals 
were treated with MRgFUS. The ablation areas obtained with both techniques were approximately 
the same, but MRgFUS has the advantage of being a non-invasive technique. Furthermore, 
treatment planning was more accurate since the position of the target areas were confirmed right 
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prior to the treatment through MRI, which it was not possible with fluoroscopy imaging before 
RFA.  
With this study, we were able to create a successful mesothelioma tumor model in pigs and 
study its characteristics in-vivo using MRI and post-mortem during necropsy. Furthermore, it was 
possible to prove the feasibility to both techniques, as well as to investigate the best parameters to 
apply them in large animal. 
 
Keywords: Malignant pleural mesothelioma, tumor model, swine, Magnetic Resonance Imaging, 
Radiofrequency Ablation, Ultrasound, Magnetic Resonance-guided Focused Ultrasound Surgery. 
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Resumo 
 
Mesotelioma pleural maligno (MPM) é um tipo de neoplasia rara que afecta a pleura, ou 
seja, a membrana que reveste os pulmões. A principal causa epidemiológica desta doença é a 
exposição a asbesto, também conhecido como amianto. Apesar das restrições impostas à utilização 
deste material nos anos 70, o período de latência da doença varia entre 20 e 50 anos o que significa 
que o pico de casos de MPM está previsto entre 2010 e 2020, podendo ocorrer até 2050 em alguns 
países.  
Para além do alargado período de latência, esta neoplasia é também agressiva com um 
tempo de sobrevivência médio inferior a um ano, mesmo com um tratamento adequado. As terapias 
convencionais para tratamento de cancro, como a quimioterapia e radioterapia, não têm demostrado 
resultados satisfatórios. Mais recentemente, uma terapia multimodal tem sido adoptada em que a 
redução do tumor primário é efectuada através de dois tipos de cirurgia, pleurectomia / decorticação 
ou pneumonectomia extrapleural. À cirurgia é associada quimioterapia ou radioterapia, para 
remover as margens do tumor primário que não tenham sido completamente extraídas e também 
para tratamento de metástases que se tenham desenvolvido noutros órgãos. Um problema, contudo, 
com este tipo de terapia é que a grande maioria dos pacientes quando diagnosticados apresentam já 
um estado de saúde muito debilitado, que não lhes permite suportar procedimentos cirúrgicos tão 
agressivos. Deste modo outras opções para a redução primária do tumor têm sido exploradas. No 
contexto deste projecto, serão abordadas as ablações percutânea por radiofrequência e transcutânea 
por ultra-sons (US) focalizados.  
A técnica de ablação por radiofrequência consiste na introdução de um eléctrodo no 
paciente, percutaneamente, ate alcançar a lesão a ser tratada. Este eléctrodo é ligado a um gerador 
de corrente de radiofrequência, que é transportada até à lesão, provocando a vibração das moléculas 
de água neste tecido. Este movimento de vibração leva á deposição de energia e, consequentemente, 
a um aumento da temperatura do tecido. Quando a temperatura aumenta acima dos 60ºC, ocorre a 
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desnaturação das proteínas celulares e as células morrem, num processo denominado de coagulação 
necrótica. O tratamento é, geralmente, guiado através de técnicas de imagiologia médica, como 
ultra-sons, tomografia computorizada (TC) e Ressonância Magnética (RM). Esta técnica tem sido 
comummente utilizada para o tratamento de tumores no fígado (carcinoma hepatocelular). 
A terapia por ultra-sons focalizados de alta frequência, por outro lado, tal como a 
denominação sugere, utiliza ondas de ultra-sons para obter a deposição de calor no tumor e, 
consequentemente, aumentar a temperatura no tecido. Tal como no caso da ablação por 
radiofrequência, quando as temperaturas obtidas são acima dos 60ºC, é possível obter-se a morte 
das células cancerígenas. O tratamento é, geralmente, guiado por US e RM. A grande vantagem 
deste método é que o transdutor que transfere a energia para a lesão é completamente externo ao 
paciente e este é, portanto, considerado um tratamento não invasivo. Em 2004, a Food and Drug 
Administration (FDA) aprovou a aplicação de ultra-sons focalizados no tratamento de fibróides 
uterinos, utilizando um sistema desenvolvido pela empresa Insightec (Israel), que utiliza RM para 
planear e guiar o tratamento. Na Europa a Comissão Europeia aprovou o uso dos equipamentos 
Phillips Sonalleve MR-HIFU e Haifu JC. 
O principal objectivo deste estudo é comprovar a exequibilidade de aplicar as técnicas 
anteriormente mencionadas no tratamento do mesotelioma pleural induzido em porcos e comparar 
os resultados entre as duas terapias. No total, a doença foi induzida em onze animais, sendo que 
dois deles não receberam qualquer tratamento, pois eram animais de controlo para avaliar o 
desenvolvimento do tumor. Cinco animais foram tratados através da terapia de ablação por 
radiofrequência e quatro porcos foram tratados recorrendo a ulta-sons focalizados. O estudo foi 
efectuado no Departamento de Radiologia da Universidade da Virgínia. 
A indução da neoplasia foi efectuada recorrendo a uma linhagem de células humanas de 
msotelioma, MSTO-211H. As células foram injectadas na cavidade torácica dos animais (porcos da 
raça Yorkshire), previamente imunossuprimidos com ciclosporina (Gengraf), perto da base do 
pulmão direito. Os animais receberam diferentes quantidades de células, variando entre 6x10
6
 e 
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13x10
6
 células. Para mimetizar o aparecimento de metástases provocadas por este tipo de tumor, as 
células foram ainda injectadas no lobo direito do fígado dos animais, à excepção dos animais de 
controlo. A inoculação foi guiada através de imagens de fluoroscopia. Imagens de RM (scanner de 
1.5 T, Avanto, Siemens) foram adquiridas anteriormente à inoculação e, posteriormente, a cada 
quatro semanas, para avaliar o aparecimento de sinais de MPM, até à data da eutanásia ou 
tratamento. O período decorrido desde a inoculação até ao tratamento foi variável entre porcos, num 
mínimo de 8 semanas e máximo de 16 semanas.    
Para a ablação por radiofrequência um eléctrodo expansível (2.0 cm de diâmetro e 15 cm de 
comprimento, LeVeen), ligado a um gerador com capacidade até 200 W (Boston Scientific). O 
tratamento foi guiado através de imagens de fluoroscopia. Os tratamentos de ablação por 
radiofrequência foram efectuados em ambos os lados e no fígado, sendo aplicados diferentes 
valores de potência para cada animal. A duração dos tratamentos foi também variável. Os animais 
foram eutanizados no final do tratamento. 
Para os tratamentos com ultra-sons focalizados, foi utilizado o equipamento da Insightec 
anteriormente mencionado, utilizado na prática clínica para tratar fibróides uterinos. Os animais 
foram tratados no Focused Ultrasound Center da Universidade da Virgínia. Dado nenhum outro 
estudo  de ultra-sons focalizados aplicados ao tratamento de mesotelioma ter sido efectuado (no 
nosso conhecimento), foi efectuado um escalamento da energia acústica depositada ao longo do 
tratamento dos animais. Cada animal foi tratado em apenas um lado da pleura e no fígado. Os 
animais foram eutanizados no final do tratamento. 
Ao longo do período de desenvolvimento da doença, o sinal mais comum de mesotelioma 
foi a presença de efusão pleural, caracterizada por áreas hiper-intensas nas sequências ponderadas 
em T2. Outro sinal também associado à neoplasia foi o aumento da espessura do diafragma, devido 
ao aumento do esforço dos animais para respirar. Apesar de não terem sido detectadas massas 
tumorais, na maioria dos animais eram observáveis adesões pleurais. Durante a necropsia, a maioria 
dos porcos revelou adesões pleurais, embora em diferentes graus de desenvolvimentos, bem como o 
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aumento do espessamento do diafragma. No entanto, em apenas dois porcos foi verificada a 
presença de fluido, provavelmente porque após os tratamentos o fluido evaporou. 
As zonas de ablação obtidas após o tratamento por radiofrequência na pleura tinham um 
tamanho variável entre 2 cm e 3 cm, com uma forma aproximadamente circular tal como expectável 
pelo design do eléctrodo. O tratamento era mais facilmente completado no lado direito, mas em 
ambos os lados as zonas de ablação correspondiam à área inicialmente escolhida pata ser tratada. 
No fígado, no entanto, havia uma distância superior a 10cm entre a lesão e a zona de ablação.  
Nos tratamentos com ultra-sons focalizados, as áreas de ablação tinham um tamanho 
variável entre 2 e 3 cm. Todos os tratamentos foram concluídos sem haver grande dispersão do 
feixe, sendo que em apenas um porco o feixe teve que ser ajustado para evitar a reflexão do mesmo 
pelas costelas. Em 3 dos 4 porcos tratados, contudo, foram verificadas queimaduras. No entanto, 
diversos estudos propuseram já mecanismos para evitar este tipo de lesão, sendo que para estudos 
futuros medidas devem ser adoptadas para evitá-los. Comparativamente à ablação por 
radiofrequência, esta técnica permitiu obter lesões de tamanho semelhante, sendo o tempo de 
tratamento, aproximadamente, o mesmo e evitando recorrer a incisões. 
Em resumo, com este projecto foi possível desenvolver um modelo de mesotelioma eficaz, 
em porcos, bem como acompanhar a sua evolução e caracterizá-lo. Foi ainda possível demonstrar a 
exequibilidade das terapias ablativas, obtendo lesões de tamanho aproximadamente igual com 
ambos os tratamentos, sendo que a ablação por ultra-sons focalizados apresenta a clara vantagem de 
ser um tratamento não-invasivo. 
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Introduction 
 
Malignant Pleural Mesothelioma (MPM) is an aggressive, although relatively rare, tumor, 
arising from the surface serosal cells of the pleural cavity. Epidemiological studies reveal that the 
exposure to asbestos fibers is the main cause of mesothelioma. The patients affected by this 
condition carry a poor prognosis (generally they survive less than one year) so it is important the 
development of imagiology techniques. So far, the preferred techniques in the assessment of the 
disease are Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). MRI, besides 
avoiding the use of radiation in the already debilitated patients, also permits to obtain images with 
better contrast. 
Although the use of asbestos has been forbidden in most developed countries since the 70’s, 
this type of cancer has a long latency period that ranges from 20 to 50 years, which means that for 
most countries the peak in mesothelioma cases is predicted to take place in the period between 2010 
and 2020. Therefore, developed countries have a great social and economic interest in the research 
of an effective therapy in the next years. Recently, multimodality therapy has been used to treat 
mesothelioma patients. Its main goal is the cytoreduction of the primary tumor by surgery, radiation 
or ablative therapy and hence, the volume of tumor debulking must be maximized. The primary 
option for mesothelioma cytoreduction is surgery. However, 90% of mesothelioma patients cannot 
tolerate it, since by the time they are diagnosed their general health condition is very poor. In this 
sense, ablative procedures, such as the ones that use radiofrequency or ultrasound waves, become 
an attractive approach.  
While Radiofrequency Ablation has been widely used in clinical practice for the treatment 
of solid tumors (particularly hepatocellular carcinoma in the liver) as well as other heart conditions, 
Focused Ultrasound only in the last decade got the approval from Food and Drug Administration 
for the treatment of uterine fibroids. This technique, however, has showed promising results and, 
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therefore, a wide range of applications are being investigated and it is one of the most 
groundbreaking non-invasive cancer therapies. 
The first aim of this project is to develop and to characterize a successful mesothelioma 
tumor model in pigs (12 animals). Animals will be divided in two groups (each group with six 
animals) and one pig from each group will be used as a control animal to characterize the tumor 
model. The second aim of this project is to treat one group of animals with RFA and the other group 
with MRgFUS, and therefore to investigate the feasibility of percutaneous RFA and transcutaneous 
MRgFUS in a swine mesothelioma tumor model. 
The first chapter of this dissertation will be a theoretical background of the aforementioned 
disease and the ablative procedures. The second and third chapters will describe the methods used 
to achieve the goals proposed and the results obtained with the experiment, respectively. In the 
fourth chapter, the successful points and pitfalls of the study, as well as the comparison between 
both therapies, will be discussed. Finally, the future directions of MRgFUS will be briefly 
approached in the section dedicated to the final conclusions. 
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CHAPTER I 
Malignant Pleural Mesothelioma 
 
Malignant Pleural Mesothelioma (MPM) is an aggressive type of cancer that develops from 
mesothelial cells lining in the pleura. Epidemiological studies reveal that the exposure to asbestos 
fibers, from industrial and environmental sources, is the main cause of mesothelioma [1, 2]. 
Although it is believed that in the United States the peak of mesothelioma occurred in 2004, this 
condition is still a problem worldwide, with an increasing number of diagnosed cases in Europe 
every year [1]. Figure 1 represents the number of deaths in the United States in 2002, due to some 
of the diseases that affect a larger number of people in this country and asbestos-related deaths are 
higher than other respiratory diseases, such as asthma and tuberculosis. 
 
 
Figure 1 – Asbestos-related deaths in United States (2002) comparatively with other conditions. 
The number of deaths is superior to conditions such as skin cancer, asthma, hepatitis and 
Hodgkins disease [3].  
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Asbestos utilization was forbidden in most developed countries in the70’s. Malignant 
pleural mesothelioma, however, is associated with a long period of latency between the exposure 
and the expression of the disease, ranging from 20 to 50 years, since the mineral fibers get lodge in 
the pleura and the organism cannot eliminate them easily, which permits them to be embedded in 
the pleural space for decades, continuously damaging the tissue [4].  This means that for most 
European and Asiatic countries the peak is predicted between 2010 and 2020 and it is expected 
more than 250,000 deaths in Western Europe and more than 100,000 in Japan. Patients have a 
dismal prognosis and the average survival time ranges between 4 and 12 months, regardless of stage 
[1]. MPM occurs more frequently in men and risk increases with age [1,2].  
MPM can be histologically classified in three subtypes: epithelial, the most common type 
with 50% to 60% of cases, sarcomatoid, comprising 10% of cases and biphasic, the combination of 
the other two types. Epithelial mesotheliomas have a better prognosis than the two other forms. On 
the other hand, sarcomatoid mesotheliomas are very resistant to therapy [1]. 
Besides the long latency period, pleural mesothelioma has a difficult diagnosis and it is 
very challenging to understand the early events in the malignant mesothelioma development [5]. A 
study by Hiroshima et al. [6] evaluated the early histopathological characteristics of mesothelioma 
and found out in eight early stage patients (six with epithelioid and two with biphasic 
mesothelioma) that macroscopically there was no visible tumor, but both visceral and parietal 
pleura were thickened and several adhesions were observed between them. Therefore, in early 
stages, it is not always possible to distinguish tumor masses, but adhesions and pleural effusion. In 
the advanced stages, however, nodules become larger and more confluent. Approximately 30% of 
pleural mesothelioma cases directly invade the parietal pericardium [6]. Metastatic disease is often 
associated with pleural mesothelioma. The most common site is the lymph nodes, followed by the 
visceral pleural surface of the contralateral lung. Mesothelioma may also invade the diaphragm and 
even progressively encase organs in the abdominal cavity, such as the liver, brain and bone [1, 2]. 
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 Figure 2 - Staging on Malignant Pleural Mesothelioma, by 
characteristics of tumor, lymph nodes and metastases [7]. 
 
 Until now, there are no screening tests to detect the early stages of mesothelioma, but there 
are three staging systems widely used to evaluate this condition. The International Mesothelioma 
Interest Group (IMIG) defined a staging system based on the characteristics of the tumor, lymph 
node involvement and metastatic disease, represented on figure 2 [7]. 
MPM is very difficult to 
treat, partly because there are 
few clinical trials, since the 
number of patients is relatively 
small compared to other cancer 
types, the different histological 
characteristics between patients 
and also a mismatch between the 
radiographic and surgical 
information [1, 5]. However, 
since the increase of diagnosed 
cases in the last years, several 
studies investigated the different 
approaches in the treatment of 
both resectable and unresectable 
disease [1,2]. In the first case, 
surgery is the primary option, 
generally combined with 
adjuvant radiotherapy or 
chemotherapy. On the other 
hand, in case of unresectable 
disease, chemotherapy has been commonly used and more recently biological therapy.  
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For MPM patients, two types of surgery are performed, pluerectomy/decortication (P/D) 
and extrapleural pneumonectomy (EPP), both very aggressive procedures. P/D is an open 
thoracotomy for removal of parietal and visceral pleura as well as the mesothelium covering the 
pericardium and diaphragm. EPP consists of removal of the affected tissue in the hemithorax, 
including visceral and parietal pleura, diseased lung, mediastinal lymph nodes, pericardium and 
diaphragm [1, 2, 5]. This procedure is associated with higher morbidity rates. One of the problems 
with surgery is both local and distant recurrence of the tumor, because neither of the procedures has 
the ability of completely eliminating the residual microscopic disease [1]. Therefore the use of 
adjuvant therapies is necessary to complete the treatment. Radiotherapy is used either in the surgical 
incision sites to prevent tumor seeding or in the entire hemithorax to avoid the recurrence of the 
tumor in the thoracic cavity and the spread of tumor cells to distant organ. This is the only adjuvant 
therapy that prevents local recurrence of the disease. Chemotherapy may also be used as an 
adjuvant or neoadjuvant therapy for resectable disease, concurrent with radiotherapy, permitting an 
overall survival variable between 16.6 and 25.5 months [1]. 
Chemotherapy is, nevertheless, the primary choice for MPM treatment when the disease is 
unresectable, although MPM is more resistant to this kind of treatment than other tumors. Cisplatin 
has been the most common agent used [1, 2]. However, several studies showed that the combination 
of cisplatin with other agents, such as pemetrexed, increased the overall survival rate from 9.5 
months using only cisplatin to 12.1 months, as well as a general increase of patients life quality in 
the first weeks of treatment. Until this point, pemetrexed has been used as front-line chemotherapy 
and no salvage regimen has been approved yet to MPM. Jassem et al. however conducted a phase 
III clinical trial to prove that a salvage setting in pemetrexed administration improves tumor 
response, although they were not able to show an increase in the overall survival for patients that 
did not have a positive response in a front-line regimen of chemotherapy [1].  
Several imagiology techniques are available for the diagnosis of MPM. Computed 
Tomography (CT) has been used as the primary imaging modality for the diagnosis, staging and 
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Figure 3 – Contrast enhanced coronal T1-weighted image and axial LAVA images of a 
patient diagnosed with pleural mesothelioma, revealing circumferential pleural nodules, 
without diaphragmatic (white arrow) or chest wall invasion [9]. 
monitoring of mesothelioma treatment. Magnetic Resonance Imaging (MRI), however, provides 
additional information to CT because of the excellent contrast resolution, advantageous in the 
differentiation of malignant from benign disease and metastatic involvement of chest wall and 
diaphragm [8].  
Perfusion MRI has been widely used to assess tumor vascularity and vascular permeability. 
To detect tumor invasions of the adjacent structures it is common to use contrast-enhanced T1 fat-
suppressed sequences. High signal intensity comparatively to the adjacent musculature suggests 
malignant disease. High intensity is visible in T1-weighted (T1-w) and T2-weighted (T2-w) 
sequences (figure 3).  Furthermore, it is possible to distinguish pleural effusion, frequently observed 
as focal areas of very high signal intensity on T2- w images. The most promising MR approach, 
however, is to use perfusion MRI, with the injection of a contrast agent. Generally, in clinical 
practice, gadolinium (Gd) is the chosen contrast agent [8, 9].  
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To perform MR imaging in mesothelioma patients one has to take in consideration that the 
protocol needs to be done in a reasonable time frame (in 15 to 30 minutes). The most common 
approach to MR image mesothelioma protocols is to use fast sequences for single or multiple 
breath-hold imaging, permitting a reasonably high spatial resolution imaging and short echo time 
(TE). The main goal is to obtain as much signal as possible before the signal decays [8,9]. 
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CHAPTER II 
Ablative Therapies 
 
2.1 Radiofrequency Ablation 
 
Radiofrequency ablation is a minimally invasive tumor treatment, mostly used in clinical 
practice to treat small renal masses [10]. During the procedure, the ablation needle is placed directly 
in the target tissue and one or more electrodes are deployed from the tip of the needle [10, 11]. 
These electrodes have small thermocouples responsible for temperature monitoring. The needle is 
connected to a generator capable of producing an alternating current that flows through the 
electrodes into the tissue, therefore exposing tissues to an electromagnetic (EM) field (figure 4) 
[10]. The dipole molecules in the tissue, mostly water, adjacent to the RF electrode, vibrate rapidly 
in the direction of the alternating current. Molecules further away in the other hand move by the 
molecules vibrating near them, which consequently causes a frictional energy that deposits heat and 
increases the temperature in the tissue. When 60ºC are achieved, protein denaturation occurs and 
the coagulation necrosis starts, resulting in a quasi-instantly cell death. Tissue ablation due to 
thermal effects occurs because the cells in soft tissue lose their ability to conduct electric current, 
which causes an increase in tissue impedance [10, 11]. The majority of the heat deposits in the 
tissue surrounding the probe. An exponential decrease in the temperature happens moving away 
from the probe due to the poor conductivity of tissues. Besides the small active electrode placed in 
the target zone, radiofrequency ablation procedure makes use of a large dispersive electrode that 
closes the circuit and it is used so that the current could pass freely in the patient (figure 4), without 
a significant increase in the heat except in the tip of the RFA probe due to their larger surface area 
comparatively with the tip [10].  
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 The radiofrequency generator power and depth of the lesions are limited for thrombus 
formation that happens when the electrode-tissue temperature rises above 80ºC. At 100ºC death 
cells occurs as evaporation and microbubbles containing nitrogen are produced, resulting in 
desiccated (or charred) tissue [10, 11]. Adherent tissue is a common finding when removing the 
probe due to the temperature rising above the aforementioned threshold, which results in boiling of 
the plasma and adherence of denatured proteins to the probe tip (figure 5). The desiccated tissue 
acts as an insulator that prevents the current to move to the adjacent organs, therefore compromising 
the procedure. 
  
Figure 4 – A: RFA ‘circuit’. Electrode acts like the cathode and the grounding pads as the anode. The 
procedure is very dependent on tissues electric and thermal conductivity since the patients is part of the 
circuit; B: The RFA electrode produces an alternating electromagnetic field, resulting in the adjacent 
molecules motion, that are act as a source of heat for the RFA procedure [10]. 
A B 
Figure 5 – Comparison between the ablation results with slower and faster temperature rise. The final 
ablation area of the top row is larger than the one in the bottom row, since the faster temperature increase 
resulted in desiccated tissue around electrode tip before the maximum ablation area has been achieved. 
Further deposition of energy in the adjacent tissue is hard to obtain because resistance become too high [10]. 
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To avoid the problem of tissue desiccation and scarring, several models of needle designs 
and generator programs were developed. Some electrodes have a ‘Christmas tree’ configuration 
being possible to extend and retract the electrodes of the adjacent tissue (figure 6A). Other type of 
needles has retractable electrodes, that when deployed assume an ‘umbrella’ form (figure 6B). 
Other types include the use a hollow needle with an exposed and closed tip of variable length which 
contains a thermocouple (figure 6C). Most electrodes used in clinical practice use a monopolar 
configuration. More recently, however, bipolar systems were developed in which two or more 
electrode are placed into or around the tumor, without being required the use of grounding pads, 
since the current flows from one electrode to the other [12, 13]. Several RF generator systems are 
also available to support the design of the different electrodes, using either temperature or 
impedance to maximize the diameter of the ablated area and each one with a specific treatment 
algorithm.  
 
 
A common problem when using RFA thermal ablation is the presence of large blood 
vessels (generally 3 mm or larger) due to the «heat sink» effect resultant from the heat lost, 
consequence of the cooling effects of blood flow. This undesirable effect limits the ablation area; 
Figure 6 – Different types if RFA probes. A: ‘Christmas tree’ configuration by RITA Medical Systems; B: 
‘Umbrella’ shaped array from Radiotherapeutics, similar to the one used in this project; C: Single cooled-tip 
needle from Radionics [12]. 
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Figure 7 – Color simulation of a cross section of an RF ablation local temperature effect: on the left , an 
image without any blood vessel; on the right, an image simulation temperature disturbance due to the 
presence of a blood vessel (white). 
hence some residual tumor margins may be untreated, increasing the odds of local tumor recurrence 
[10, 14]. 
The preoperative evaluation is generally made based in CT or MR imaging used to study 
the number and size of tumor masses and their position relatively to sensible structures such as 
blood vessels (figure 7). The most common approach for the RFA procedure is a percutaneous 
treatment because is the least invasive, with an associated low morbidity rate and it can be 
performed on an outpatient basis since only conscious sedation is required. However, both 
laparoscopy and laparotomy RFA have been used to treat liver tumors. For the needle placement, in 
clinical practice, US, CT and MRI are used to guide the treatment, although other techniques may 
be used. US is the preferred method, but has limited ability to assess the effectiveness of the 
treatment providing only a rough estimation of the ablation spot size. Furthermore, this technique 
does not permit to obtain images with defined tumor margins and consequently they are not 
removed which does not prevent local recurrence of the tumor. Almost all  patients feel transient 
side effects, nausea and pain, during and after the procedure. Some of the patients (25%) also have 
some late flu-like symptoms, such as fever and general malaise, 3 to 5 days after the ablation. 
 
 
 
 
 
 
 
 
 
The most common application for RFA is the treatment of the liver, in both hepatocellular 
carcinoma and metastatic liver tumors. When ablating the tumor, besides the blood vessels, the 
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physician may also plane the treatment avoiding bile ducts, gallbladder, diaphragm and bowel, 
because patients with masses near these structures feel more pain during and after the ablation. The 
main concern when ablating near the blood vessels is that the blood flow in the vessels cools the 
tissue reducing the heating and therefore decreasing the effectiveness of the treatment. Patients are 
considered candidates if they have less than 5 masses, each less than 5 cm in diameter and no 
evidence of extrahepatic tumor. Figure 8 shows the results of RFA procedures in hepatocellular 
carcinoma patients. Rossi et al. [12] showed that it was possible to achieve complete necrosis in 
almost 90% of the patients with hepatocellular carcinoma in 6 months when treating tumors with a 
diameter smaller than 3 cm.  Livraghi et al. [12]on the other hand conclude that for tumor larger 
than 3 cm the complete necrosis success decreased to 71% (3.1-5 cm).  
Figure 9 – CT scans from a 46-year old patient with metastatic colon cancer. A: Before the treatment a 3-cm 
metastasis is observed in the posterior right lobe of the liver. B: Immediately after the ablation a thermal 
injury is observed in the treated area and there is no evidence of residual tumor. C: Follow-up 3 months after 
ablation shows recurrent tumor in the margins of the ablated area. D: Immediately after re-ablation, it is 
possible to observe an enlarged thermal injury with no evidence of recurrent tumor [12]. 
Figure 8 – Results of several studies about Percutaneous Radiofrequency Ablation of Hepatocellular 
Carcinoma [12]. 
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 Radiofrequency ablation has also been used for lung cancer treatment. Simon et al. [15] in 
2007 published a study about long-term survival, local tumor progression and complications rates in 
153 patients submitted to CT-guided RFA in the lung between 1998 and 2005. The overall 
conclusions were that the treatment has promising results in long-term survival rates (1-, 2-, 3-, 4-, 
and 5-year survival rates, respectively, were 78%, 57%, 36%, 27%, and 27%) and local tumor 
progression outcomes (1-, 2-, 3-, 4-, and 5-year local tumor progression–free rates, respectively, 
were 83%, 64%, 57%, 47%, and 47% for tumors 3 cm or smaller and 45%, 25%, 25%, 25%, and 
25% for tumors larger than 3 cm). Nevertheless, there was a significant difference between the 
survival curves of patients with large (> 3cm) and small tumors, a common finding in studies with 
RFA. 
Research on RFA for kidney, breast and bone tumors has also been widely developed. 
Besides tumor ablation, RFA has been applied in cardiac arrhythmia and pain management. RFA 
was introduced in clinical use for cardiac arrhythmia to replace the direct-current shocks, therefore 
avoiding the stimulation of cardiac and skeletal muscle, minimum discomfort and the discrete 
resultant lesions from ablation that combined with the short treatment time reduce post procedural 
complications [16]. Therefore it presents the advantages of symptoms relief, improvement in the 
quality of life, discards the need for lifelong antiarrhythmic-drug therapy and allows long-term cost 
savings.  
 
2.2 High Intensity Focused Ultrasound Therapy 
 
High Intensity Focused Ultrasound (HIFU) therapy is an emergent, non-invasive treatment 
with great potential for tumor ablation, hemostasis, thrombolysis and targeted drug/gene delivery 
[17, 18]. This therapy relies on the effects of Ultrasound (US) waves when focused on specific 
target tissue of the body, resulting in an increase of tissues temperature that play an important role 
in tumor ablation and hemostasis, or other non-thermal effects, significantly important in 
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thrombolysis or targeted drug/gene-delivery through cavitation mechanisms. For these last 
applications low intensities US are used [17].   
Ultrasound has a frequency higher than human ear can detect (superior to 20,000 Hz). By 
definition, sound is a disturbance of mechanical energy travelling to a medium, which implies that a 
medium has to be present for sound propagation. As the ultrasound wave propagates molecules 
within the medium oscillate around their rest position in the direction of the wave, forming 
compressions and rarefactions that propagate the wave. The ultrasound energy attenuates 
exponentially as the wave travels through the tissue [17]. An important parameter when 
characterizing ultrasound wave propagation is the acoustic intensity that it is defined as the rate of 
energy flow through a unit area, normal to the direction of the propagation.  US have been mostly 
used in a diagnosis sense, showing minimal effects in the biological tissue. However, by being able 
to maximize the energy accumulation in a specified target point it is possible to induce significant 
changes in the definite biological tissue while sparing the adjacent organs as well as the skin [17].  
As aforementioned, thermal effect and acoustic cavitation are the mechanisms more 
significant in US and, therefore the resulting reactions in tissue by these effects have been widely 
investigated and are now relatively well-understood. The first one results from the absorption of US 
energy by the tissue, since the waves cause vibration and rotation of the molecules present in the 
tissue and consequently frictional heat is generated. The US-induces changes by hyperthermia are 
dependent on the temperature (T) reached and the duration of beam contact in the tissue. Hence, the 
result may be an increase in tissues susceptibility for chemotherapy or radiotherapy (T>43ºC during 
1 hour) or protein denaturation, also referred as coagulative necrosis (T=56ºC during 1 second) 
[17]. The increase in the temperature is linearly-proportional to sonic intensity, as demonstrated by 
equation 1 [17]: 
  
                                                                   
  
  
  
   
   
                                                                (1) 
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being T = temperature (ºC), t = time (sec), α = absorption coefficient (~ 0.03 Np/cm in tissue-like 
medium at 1MHz), I = sonic intensity, ρ = density (~ 1g.cm-3 in tissue-like medium) and Cp = 
specific heat (~ 4.2 J/gºC in tissue-like medium).  
 The ultrasound beam is focused to obtain very small focal spots, which allows a very 
precise treatment (figure 10). For example, using a 1.5 MHz transducer, it is possible obtain a focal 
spot with 1 mm of diameter. The length of the focus is generally 5 to 20 times larger than the 
diameter []18. Focusing the beam allows to concentrate US energy deep in the tissue, sparing the 
adjacent organs and avoiding the ultrasound attenuation across the area within the sonication path. 
To improve beam focusing, transducer arrays have been developed containing signals with different 
phase to obtain a common focal spot. These systems permit electrical focusing then allowing 
multiple focal spots simultaneously which contributes to decrease treatment time (figures 11 and 
12) [18]. 
 
 
Figure 10 – A: HIFU-induced biological effects by hyperthermia. US waves are focused into a small spot, 
where acoustic pressure increases and consequently rising tissue temperature. B: Properties of a geometrically 
focused transducer. C: Normalized acoustic pressure in the direction of ultrasound propagation for a 1.5MHz 
transducer with a radius of curvature of 8 cm and diameter of 10 cm [18]. 
43ºC 56ºC 
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Figure 11 – Different configurations for the use of 
phases-arrays transducers to produce multiple 
focal spots, steer the focal spot to different 
locations and correct aberrations [18]. 
 
 
 
 
 
 
 
 
 
 
 
Interfaces between different types of tissue are a problem in HIFU. Ultrasound is 
transmitted between surfaces of soft tissue with a small amount of wave reflected back. Between 
soft tissue-bone the amount increases to one third of the incident energy [19]. Furthermore, the 
amplitude attenuation coefficient of US is 10 to 20 times higher in bone than in soft tissue, which 
means that the beam is rapidly absorbed within the bone [17]. The main problem however occurs in 
the interface between gas and tissue, because gas has lower density than water or soft tissue and 
therefore almost all energy is reflected back . This is the main reason why (so far) lungs have not 
been considered an option for HIFU treatment [20].  
Acoustic cavitation results in the formation of gas or vapor filled bubbles. This occurs when 
a US wave with an intensity superior to a specified threshold interacts with biological tissue 
Figure 12 – Different transducers for focusing 
ultrasound. A: Spherically-curved transducer; 
B: Flat transducer with interchangeable lens; C 
and D: phased-array transducers [17]. 
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creating a negative pressure due to ultrasound wave rarefaction which can be large enough to pull 
gas out of the tissue and consequently form a bubble. The threshold depends on pressure amplitude 
and the frequency of the sound wave and type of tissue where it occurs. After bubble formation the 
cavitation may be stable (non-inertial cavitation) or unstable (inertial cavitation), depending on the 
resonant size of the bubble. In the non-inertial cavitation case the bubble presents radial oscillations 
in a resonant size in the frequency of the ultrasound beam. The bubble may however expand above 
its resonant size, which eventually may lead to it disintegration and collapsing. The resultant 
thermal and mechanical effects from acoustic cavitation are unpredictable and sometimes cause 
unexpected damage in the tissue. 
The thermal effect promoted both by US absorption and acoustic cavitation is on the base 
of Focused Ultrasound Surgery (FUS) for tumor ablation. For this application, the range of spatial 
average intensity is 100-10,000Wcm
-2
. Although US absorption is the preferential effect to obtain 
coagulative necrosis, since the reactions in the biological tissue are predictable, acoustic cavitation 
effects have shown to improve the efficacy of the treatment, by increasing the ablation area, and 
decreasing the procedure time. 
The imagiology options used to guide the HIFU treatment are usually B-mode US images 
and MRI. The B-mode images do not give information about the increase of temperature, but 
instead show the activity of acoustic cavitation or tissue boiling, which introduces an error in the 
actual location where necrosis occur. Further studies are necessary to evaluate the alteration in 
sound speed with tissues temperature which can be a future option for US thermometry. Ultrasound 
imaging, however, besides being relatively low-cost, allows real-time monitoring and a precise 
simulation of HIFU beam propagation path. Nevertheless, the poor imaging contrast and limited 
field of view are disadvantages in contrast with MRI. Furthermore, MRI permits to quantify the 
temperature and generat  thermal dose maps. MR thermometry is based on the proton resonance 
frequency (PRF) shift of water, since the water proton resonance frequency changes with 
temperature due to alterations in the hydrogen bonds in the water, then altering electron screening 
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Figure 13 – Temperature images acquired during sonication to evaluate targeting. A and B: Images acquired 
before correcting focal coordinate; C and D: images acquired after correction. A and B: images acquired with 
temperature imaging perpendicular to the ultrasound beam direction. C and D: images acquired with 
temperature mapping along the beam direction [18]. 
of the nucleus. This effect can be assessed with phase subtraction MR images. The temperature 
difference is given by equation 2 [18]: 
 
                                                                     
  
       
                                                                    (2) 
 
where    is the difference in the images phase before and after the sonication, TE the eco time and 
   the proton resonance frequency. Therefore, the thermometry sensitivity is not dependent on the 
type of tissue, although some inaccuracies are verified in fat tissue (figure 13). One of the main 
disadvantages of the technique is its sensitivity to motion, which introduces a relevant source of 
error. Breath-hold techniques may be a solution by reducing the movement of abdominal and 
thoracic organs, despite implying short sonication times.  
 
 
MRgFUS received the approval of Food and Drug Administration (FDA) in 2004 for the 
treatment of uterine fibroids, the most common benign neoplasm in women, using the General 
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Electrics (GE) Insightec ExAblate 2000 equipment. Additionally, Philips Sonalleve MR-HIFU and 
Haifu JC and JC200 have European Commission (CE) approval [18]. Until 2004, the long term 
option for women with this condition were radical hysterectomies, a very aggressive approach, or 
no treatment at all, resulting in anemia, chronic pain or prolonged infertility. Although 
myomectomy and uterine artery embolization are now viable options, FUS results are very 
promising. MRgFUS allows an outpatient procedure, with a short recovery time and minimal post-
procedural complications [21]. At our center, this treatment is performed with the ExAblate 2000 
device, from InSightec and MR images are used to plane tumor treatment in all three planes. 
Ultrasound beam path is carefully defined in order to avoid bowel loops, bladder, scar tissue and the 
sciatic nerve. Initially a low-power sonication is performed to detect the focal spot, providing if 
necessary, the images for the operator to redefine the focal spot position. After the focal spot is 
located in the ablation area, the power is increased and temperature is monitored until increases 
over 60ºC. Several sonicatons are performed to ensure that the entire area is treated and by the end 
of procedure the necrotic area is imaged with contrast enhancement, to verify the extension of 
nonperfused necrotic tissue. By 2011, more than 6000 patients have been treated with MRgFUS, 
5400 in clinical practice. Most of the times, it is possible to obtain more than 50% of fibroid volume 
reduction with minimal or no side effects [18]. 
One of the problems when treating larger volumes is the time required to cover the entire 
mass, particularly due to the cooling time required between sonications to avoid a thermal build-up 
that occurs if the beam energies overlap. Several strategies have been developed, such as redefining 
sonication order or the use of microbubbles that enhance the heating if within the focal spot, 
reducing energy deposition in the adjacent tissue [18].  
Several studies have developed to evaluate the feasibility of FUS in the treatment of liver 
(figure 14), prostate and breast cancer. In the liver, image-guided FUS has been used in both focal 
ablation and palliative tumor reduction [22]. This application, however, presents several challenges, 
such as the presence of the rib cage that blocks the beam passage, leading to a restriction in the 
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volume to be treated. Respiratory motion of the liver also makes it difficult for an accurate targeting 
and introduces errors in the thermometry values. Nevertheless, bread-hold approaches, as well as 
technological developments (transducer designs and arrays alignment) will allow the increase in the 
interest of this application over other thermal therapies widely used, such as radiofrequency ablation 
and cryotherapy, since FUS is non-invasive and can be repeated as needed [18].  
 
 
Most of prostate cancer treatment with FUS have been guided by US, making use of two 
particular devices, Ablatherm and Sonablate, that combine a FUS transducer with a US rectal probe. 
FUS with a trans-urethral approach is also being investigated. These procedures are performed 
under anesthesia. The studies, however, show better results when combining FUS with hormonal 
therapy. Several adverse effects from FUS treatment of the prostate, including urinary retention, 
stress incontinence, bladder outlet obstruction, urinary tract infection and urethrorectal fistula, as 
well as high degrees of impotence. The side effects are in-line with the ones experienced using 
other types of prostate therapy.The use of MR as the imaging guidance method could benefit FUS 
Figure 14 – MRgFUS of hepatocellular carcinoma. Left: Post-treatment image in coronal plane showing 
entire thermal dose. Right: contrast-enhanced MRI showing focal nonperfusion [18]. 
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treatment of prostate cancer through improved thermometry and tumor visualization, reducing the 
adverse effects [18]. 
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CHAPTER III 
Materials and Methods 
 
In this chapter, the methods and equipment used to induce the disease in the animals will be 
described, as well as the approaches developed to treat the pigs with RFA and MRgFUS. Protocol 
for all the procedures was approved by the Animal Care and Use Committee (ACUC). 
 
3.1 Tumor Induction 
 
For this study 13 Yorkshire female pigs (~25 lbs) were used. Animals started receiving 
cyclosporine (orally) (Gengraf Oral Solution, MA) 3 to 7 days prior tumor inoculation, in order to 
become immunosuppressed. The initial dose was 10 mg/Kg/day, being then increased to 20 
mg/Kg/day. Cyclosporin was maintained 4-12 weeks post inoculation. Tumor model was developed 
using a human mesothelioma cell line, MSTO-211, purchased from American Type Cell Culture 
(ATCT). Cells were grown at 37
o
C in T-225 flask (corning) using RPMI media (Invitrogen) plus 
10% fbs at 37
o
C.  When confluence reached 70%, cells culture medium was removed and 
discarded; cell layer was then rinsed with 0.25% (w/v) Trypsin- 0.53 mM EDTA (Invitrogen). 
Trypsin-EDTA (10 mL) was added to each flask and cells were under an inverted microscope until 
cell layer was dispersed. 10 ml of complete growth medium were added to each flask. After 
dispersed by gently pipetting, cells were harvested and counted on a hemocytometer and 
resuspended in PBS at a final concentration of 10
6
 cells per ml. MSTO-211H cells were 
characterized for developing biphasic mesothelioma and it is considered a very aggressive cell line 
compared to others used for developing this kind of tumor, with high migratory and invasive 
features [23, 24]. Animals were anesthetized for the entire procedure (induction with 6mg/kg 
Telazol and 2mg/kg Xylazine, maintenance with 2% isoflurane). Cells were injected in the pleural 
space in the right lower hemithorax, between the ribs, under fluoroscopy guidance (Siemens, 
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Figure 15 – Setup environment for cell inoculation. Fluoroscopy allows to clearly distinguishing the liver, the heart 
and the ribs, therefore guiding the procedure. Inoculations were performed in the right side in the intercostal spaces. 
Arcadis, PA) (figure 15). Cells were also introduced in the liver in an attempt to reproduce 
metastatic disease. The procedure was performed, using a 22-gauge needle (22Gx6TW Chiba 
Needle, Becton Dickinson Medical Systems), inserted between the ribs. The number of cells 
injected in each pig and dose of cyclosporine are represented in table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Animal # 
Cell solution injected in the 
pleural space (mL) 
Cell solution injected in 
the liver (mL) 
Cyclosporine Dose (mg/Kg/day) 
1 6 Not inoculated 10 (until euthanasia) 
2 13 Not inoculated 10 (until euthanasia) 
3 11 2 20 (until 12 weeks post-inoculation) 
4 5 2 20 (until 12 weeks post-inoculation) 
5 5.5 1.5 20 (died after inoculation) 
6 9 2 20 (until 12 weeks post-inoculation) 
7 7 2 20 (until 8 weeks post-inoculation) 
8 7 2 20 (until 8 weeks post-inoculation) 
9 10 2 20 (until 8 weeks post-inoculation) 
10 5 2 20 (until 4 weeks post-inoculation) 
11 6 2 20 (died after inoculation) 
12 8 2 20 (until 4 weeks post-inoculation) 
13 8 2 20 (until 4 weeks post-inoculation) 
Table 2 – Quantity of cell solution (106 cells/mL) injected in the liver and right pleural space, as well as the 
dose and ending time-point for cyclosporine administration.  
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 Animals were imaged at baseline and followed-up every 4 weeks until 8, 12 or 16 weeks 
post-inoculation (figure 16). MRI was performed in a 1.5T scanner (Avanto, Siemens Healthcare, 
PA). Two coils were simultaneously used, a body array coil and a spine array coil (Siemens, PA). 
Contrast agent (Gadolinium: Omniscan, Novaplus, PA and Magnevist, Bayer, NJ) was given in a 
1mL/lb dose. To avoid motion artifacts, pigs were artificially ventilated and most of MR images 
(excepting T2-Blade sequence) were acquired in a breath-hold regimen. The ventilator was set to an 
inhalation period of 60% of the breathing cycle and an exhalation period of 40%.  Five MR pulse 
sequences were used: Haste (fast spin-echo T2-weighted sequence); Blade (T2-weighted sequence); 
VIBE (volume interpolated gradient echo sequence); True FISP (fast imaging with steady state 
precession); TWIST (Time-resolved angiography sequence). Changes observed in the pigs’ pleura 
during follow-ups were measured using ImageJ, a free-software that allows manually selecting 
regions of interest and calculating their areas and width. For this purpose, True FISP images were 
used. 
 
3.2 Radiofrequency Ablation Procedures 
 
Animals #3, #4, #6, #7 and #9 were treated at the end with percutaneous Radiofrequency 
Ablation. For this, we used a RF 3000 Radio Frequency Generator (Boston Scientific, MA) (figure 
17), an impedance-based feedback system and 200 Watt of power capacity. This equipment allows 
the connection of 4 ground pads for heat dispersion (Electrosurgical Ground Pad with Safety Ring, 
Novaplus, CA), that were put in the lower part of the abdomen of the pig in a supine position. A 2.0 
Figure 16 – Time line of the procedures. Pigs were treated at different timepoints. 
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cm diameter and 15.0 cm length LeVeen needle (Boston Scientific, MA) with an ‘umbrella’ 
configuration was used (figure 18). Animals were anesthetized and kept under artificial ventilation 
in a supine position for the entire procedure. The area to be ablated was defined based on the most 
recent MR images. The treatment was guided under fluoroscopy imaging (Siemens Arcadis, PA), 
because the RFA equipment was not MRI compatible. For the treatments, the impedance-base 
feedback algorithm suggested by the equipment manufacturer, Boston Scientific Company, was 
followed. For the 2.0 cm needle, the manufacturer suggests a 30 W starting power. The wattage is 
increased at a 10W/min rate until reach a power of 60 W. If a roll-off (rapid decrease of power) 
occurs, the system shuts down the treatment must be re-started at half of the roll-off power, 30 
second later. Animals were re-imaged with MRI immediately (30 to 90 minutes) after treatment 
[25]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 - 3000 Radio Frequency Generator [25]. 
Figure 18- ‘Umbrella’ needle used for the RFA treatments. Left: ‘umbrella’ needle from Boston 
Scientific [25]. Right: 2.0 cm needle used for the project. 
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3.3 MRgFUS procedures 
 
Animals #8, #10, #12 and #13 were treated with subcutaneous MRgFUS at the University 
of Virginia’s Focused Ultrasound Center. The center is equipped with the ExAblate 2000 OR 
system (Insightec, Israel), with a portable patient table that it is docked to MR scanner (3T, GE) 
during the procedures [26]. Insightec software allows an automatic 3D treatment planning for 
effective ablation in minimum time and MR-thermometry in real time. Pigs were maintained in a 
prone position. During treatment MR images were acquired using LAVA and FIESTA pulse 
sequences which are equivalent to the VIBE and True FISP sequences in the Siemens MR scanners. 
After treatment planning localization of the FUS focal spot was achieved with a low power ablation 
in the liver. After the focal spot position was determined, the coordinates of the ablation volume 
were introduced, focal spot was repositioned and power and duration of the sonication adjusted. 
Animals were re-imaged with MRI after treatment. 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 – Software for MRgFUS treatment planning by Insightec. The region colored green 
corresponds to the planned ablation area (pig #8). The green square represents the position of the 
transducer. Sonication spots were defined within this region. 
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After being treated, animals were euthanized (Euthasol, 1ml/10lbs). Both thoracic cavity 
and liver were exposed to examine the macroscopic histological characteristics of the tumor model, 
as well as to characterize the treatments. An incision was made parallel to the sternum and the ribs 
were cut in the lateral line, having the thoracic cavity exposed anteriorly.  
  
Figure 20 – Left: The blue circles above the diaphragm represent two the focal spots planned to 
treat the lesion, both localized inside the green square. Right: Saggital view of the image used for 
treatment planning. The rectangles represent the depth of the focal spots. The blue region 
corresponds to the beam path across the adjacent tissue. 
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CHAPTER IV 
Results 
 
This chapter will be divided in three sections; each one describing the results obtained in 
the tumor model development, radiofrequency ablation and MRgFUS treatments, respectively. 
 
4.1 Tumor model 
 
Pigs were followed every four weeks after their inoculation to evaluate tumor development. 
Control animals, pig #1 and #2 received an unequal number of mesothelioma cells and a lower dose 
of cyclosporine A to evaluate the effects of both parameters in the tumor development. Analysis of 
both MRI and necropsy revealed a faster disease development in pig #2 which received more than 
twice the number of cells compared with pig #1.  
Since tumor masses were not observed for these two pigs the dose of cyclosporine was 
doubled for the remaining pigs. Some mild side effects, such as vomiting (pig #3, #6), loose stools 
(pig #6) and diarrhea (pig #6) were experienced during the study. However, dose was not reduced in 
order to improve tumor development over time, since the symptoms were not very debilitating for 
the animal.  
Pigs #5 and #11 died immediately after the inoculation procedure. Pig #5 was injected with 
the mesothelioma cells in both pleura and liver without being mechanically ventilated. By the end 
of the procedure the animal was moved from supine to prone position and stopped breathing, 
although fluoroscopy images revealed that its heart kept beating and lungs were not collapsed. 
Anesthesia was reversed and the pig was mechanically ventilated, but after few minutes the heart 
stopped beating (confirmed by fluoroscopy) and resuscitation was concluded. MRI analysis 
revealed some inflammation in the left lung, but no further signs of previous disease that could lead 
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to a respiratory complications were observed. Pig #13 was inoculated as a replacement of pig #5. 
Pig #11 was connected to a ventilator for the entire procedure, however, by the end of the 
inoculation when the ventilator was turned off, the pig was not able to breath by itself, even after 
anesthesia had been reversed. MRI analysis did not show any signs of disease in the lungs or in the 
liver. No other pig was used for replacement of pig #11. 
The most prominent sign of mesothelioma development observed in MRI was pleural 
effusion, observed in several time points in all pigs, being characterized in MRI by a hyperintensity 
region in the True FISP images (Figure 21) and the presence of adhesions. In both True FISP and 
VIBE images pleural thickening was observed in several pigs. Furthermore, an increase in 
diaphragm and pericardium thickness was observed for all animals. A slightly increase in the lung 
tissue density was observed in several pigs and may be related with transient tissue inflammation.  
 
The evolution of the aforementioned disease signs was quantified using Image J at different 
time points. Graphics 1 and 2 correspond to the volume of fluid and adhesion in the thoracic cavity, 
in the left and right sides, respectively. On the other hand, graphics 3 and 4 show the results of the 
increasing in both pericardium and diaphragm thickness. 
 
Figure 21 – Main mesothelioma findings in MRI. Left: True FISP transversal image of pig #8 showing 
pleural thickening (blue arrow); Middle: True FISP coronal image of pig #8 showing pleural fluid (yellow 
arrow) and the increased thickness of diaphragm (red arrow); Right: True FISP coronal image of pig #8 
showing adhesions (orange arrow). 
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Graphic 1 – Evolution of the area covered by adhesions and fluid in the left side of thoracic cavity for all pigs. 
 
 
Graphic 2 – Evolution of the area covered by adhesions and fluid in the right side of thoracic cavity for all 
pigs. 
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Graphic 3 – Evolution of pericardium thickness for all animals. 
 
Graphic 4 – Evolution of diaphragm thickness for all pigs. 
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Table 2 summarizes the MRI findings for each pig, at each follow-up. 
Animal 
# 
Baseline 1
st
 follow-up 2
nd
 follow-up 3
rd
 follow-up 4
th
 follow-up 
1 
Healthy. Left side: 
Inflammation  
No significant 
changes. 
Left side: 
Inflammation 
 
2 
Possible 
previous lung 
disease.  
 
Right lower 
hemithorax:  
No significant 
changes. 
Bilateral 
presence of 
fluid and 
adhesions in the 
anterior part of 
thoracic cavity. 
 
3 
Healthy. 
 
Bilateral 
inflammation. 
 
No significant 
changes. 
Bilateral 
presence of 
fluid and 
adhesions in the 
anterior part of 
the thoracic 
cavity. 
Bilateral 
presence of 
fluid and 
adhesions in the 
anterior part of 
the thoracic 
cavity. 
4 
Left side: 
inflammation. 
 
Left side: 
inflammation. 
Left side:  
inflammation 
decreased. 
No significant 
changes. 
 
6 
Left side: 
inflammation. 
Left side: 
inflammation.  
Left side: 
inflammation. 
Bilateral 
presence of 
fluid and 
adhesions.  
 
7 
Right side: 
Possible 
previous lung 
disease. 
No significant 
changes.  
Bilateral 
inflammation. 
Bilateral 
presence of 
pleural fluid and 
adhesions.  
 
8 
Left side: large 
lesion near the 
heart. 
Bilateral 
presence of fluid 
and adhesions. 
Increased 
severity of 
previous 
symptoms. 
No significant 
changes. 
Animal with the 
most severe 
signs of the 
disease. 
No significant 
changes. 
Animal with the 
most severe 
signs of the 
disease. 
9 
Right side: 
inflammation. 
Left side: 
inflammation. 
Bilateral signs 
of pleural 
thickening and 
inflammation. 
  
10 
Left side: 
inflammation. 
No significant 
changes. 
Right side: 
pleural 
thickening, 
adhesions and 
fluid. 
No significant 
changes. 
 
12 
Bilateral 
inflammation. 
Some fluid, 
mostly in the left 
side. 
Bilateral 
presence of 
fluid and 
adhesions. 
Bilateral 
presence of 
fluid and 
adhesions. 
 
13 
Left side: 
severe 
inflammation.  
Some fluid, 
mostly in the left 
side. 
Bilateral 
presence of 
fluid and 
adhesions 
Bilateral 
presence of 
fluid and 
adhesions. 
 
Table 2 – Evolution of pigs’ symptoms over time. 
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Figure 22 – Macroscopic findings during necropsy: adhesions (blue arrow), increased 
diaphragm thickness (red arrow), abnormal color in the lungs (purple arrow) and 
increased pericardium thickness (green arrow). 
Several macroscopic features characteristic of mesothelioma tumor were observed during 
necropsy. The presence of adhesions (figure 22) was the main sign of disease, being present in 81% 
of the animals, although in different levels of severity. Pig #8 was the animal that revealed the 
highest quantity of adhesions, being very difficult to access the thoracic cavity and lungs during 
necropsy. On the other hand, pigs #1 and #4 did not reveal the presence of adhesions. Another 
common finding was the increased thickness of pericardium and diaphragm (figure 22), which 
muscles appeared consistently overdeveloped. Other common sign was the presence of pleural 
effusion. During the necropsy, it was possible to observe the presence of pleural effusion in the 
thoracic cavity in most pigs as determined in-vivo in True FISP MR images. In 7 of 11 animals, 
lungs did not appear to have a normal consistency, lacking firmness and being covered with several 
dark regions, being perhaps pre-necrotic tissue. 
 
 
 
 
 
 
 
A scale of disease severity (table 3) was defined based on the number and extension of the 
macroscopic features, by a reviewer.  
Disease severity Scale 
Low I 
Mild II 
Moderate III 
Severe IV 
 
Table 3 – Degrees of disease severity. 
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The symptoms and extension of the lesions observed during necropsy are summarized in 
table 4. 
 
Animal 
# 
Main macroscopic disease features 
Disease 
Severity 
1 No adhesions were observed. Pleural looked healthy. The layers in the tissue in 
the lower lobe of right lung looked different comparatively to a healthy lung. 
I 
2 Several adhesions covered both lungs.. Pericardium thickness was increased. 
Foam was observed in the lungs when collecting tissue samples. 
III 
3 
Some adhesions were observed covering both lungs. Pleura looked healthy. Left 
lung appeared normal, but right lung presented several dark areas and different 
consistency. 
II 
4 
No adhesions were observed. Diaphragm and pericardium looked healthy.  
I 
6 
Adhesions covered the entire thoracic cavity. Diaphragm thickness was 
increased (around 1 cm).  Both lungs have darker areas, mostly the right lung 
and the posterior part of the left lung. Besides the consistency of the tissue was 
different from healthy lungs. 
III 
7 
Only a few adhesions were observed, covering both lungs. Pericardium 
thickness increased and diaphragm thickness was around 0.6 cm. Left lung was 
covered with several dark regions, as well as the lower lobe of left lung.  
II 
8 Adhesions covered lungs, heart and diaphragm. Diaphragm thickness was 
around 1.5 cm. Lungs did not look healthy, with an abnormal color.  
IV 
9 
Several adhesions were observed, mostly in the right lung and around the heart. 
Pleura thickening observed in both sides. Pericardium revealed an abnormal 
increased thickness and diaphragm thickness was superior to 0.5 cm. White 
foam was present when collecting tissue samples. 
III 
10 
Some adhesions were observed. Pleura looked normal. Both lungs, although 
presenting a normal color, revealed a different consistency that indicates they 
were unhealthy. 
II 
12 
Some adhesions observed, mostly around the heart. Diaphragm thickness was 
around 1.1 cm. Thoracic cavity was full with fluid and some white biologic 
tissue was present, although it was not possible to identify its origin. Lower and 
middle lobes of right lungs had an abnormal consistency, with dark spots 
covering the lung. A significative amount of blood left the lung during tissue 
collection. Left lung also looked unhealthy but in a lower level of severity. 
III 
13 
Only a few adhesions observed mostly covering the lower lobe of left lung. 
Some areas in the diaphragm (thickness around 0.5 cm) had an abnormal 
appearance with some white areas. Lower lobe of the right lung and left lung 
didn’t appear healthy. Some fluid filled the thoracic cavity. 
II 
 
Table 4 – Macroscopic features observed in all pigs during necropsy. The severity of the disease was defined 
based on the number of features observed and their extension on pleural cavity, according to a reviewer. Stage 
one corresponds to the lowest severity degree and IV the highest. 
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4.2 Radiofrequency Ablation 
The results of pleural and liver treatments are divided in two sub-sections and the results 
from each pig’s treatment are briefly described. 
4.2.1 Pleura treatment 
 
The results of radiofrequency ablation treatment revealed that it was possible to obtain 
ablations with more than 2 cm, in around 30 minutes of treatment. For the pleura, however, it was 
not possible to use the ablation algorithm suggested by the needle electrode manufacturer (Boston 
Scientific), starting at 30W, since in the first two treatments roll-off occurred rapidly and it was not 
possible to appropriately treat the contralateral pleural side. Therefore, for pigs #3, #6 and #7, the 
power used was much inferior, starting at 2W or 5W and then slightly increasing the power at a rate 
of 2W/s. In the pleura probe often got deeply attached to the tissue, moving along with the lungs 
during entire treatment. 
4.2.1.1 Treatment of pig #4 
 
Pig #4 was treated in both pleural sides, with a starting power of 30 W for 1 minute. After 
the 1
st
 minute, the first roll-off took place and the treatment was re-started in right side of the cavity 
at 15 W (graphic 5). When ablating the left side the first roll-off occurred at 37 seconds, after 
impedance reached 1KΩ and the power decreased to 6 W. The treatment continued by setting the 
power to 15W, but the second roll-off occurred just 30 seconds after (Power = 2W; Impedance 
~1KΩ) and therefore the treatment was stopped. 
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Graphic 1 – Impedance and Power Measurements over Time in the treatment of right side of pig #4. 
 
MR Imaging done post-RFA treatment revealed that the ablated area in the right side had a 
round shape with 2 cm in diameter, consistent with the ‘umbrella’ electrode needle shape and size. 
In the left side, ablated area was slightly smaller with a diameter of approximately 1.9 cm. 
Furthermore, the intensity of the ablation area in the MRI was slightly inferior to the one obtained 
for the right side. During necropsy, ablated area in the right side appeared to be deeper in the lung 
and also had a larger size. The tissue also appeared more ablated in the right lung, particularly in the 
middle of the ablated region. Some of the tissue adjacent of both ablation spots had a darker color, 
due to the increased heat produced in these areas (figure 23). This finding is more significant in the 
left side and had a good correlation with MRI. 
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4.2.1.2 Treatment of pig #9 
 
For the treatment of pig #9, the treatment also started in the right side, at 30 W and the first 
roll-off occurred at 50 seconds. Treatment was re-started at 15 W and it was maintained for 2 more 
minutes as represented in graphic 6. To treat the left side, it was not possible to start at 30 W since 
the system didn’t allow it and therefore we decreased the starting power for 15 W. Nevertheless the 
first roll-off occurred at 30 seconds (power = 5 W; impedance = 218 Ω). The second attempt started 
with 10 W; however 30 seconds after the system had decreased the power to 4 W. A pause in the 
treatment was maintained for 30 seconds as recommended by the manufacturer. More 4 attempts in 
continuing the treatment were performed, with starting powers between 10 W and 15 W for 1 
minute, but the roll-off always occurred before the duration planned for each attempt and therefore 
the treatment was ended. 
Figure 23 – A: MR image (True FISP) used for treatment planning in the right (white arrow) and the left 
(blue arrow) sides. B: Needle placement in the right side (Fluoroscopy image); C: Post-ablation MRI (True 
FISP), showing the ablated area in the right side (green arrow); D: Necropsy image showing the ablated 
area in the right side (purple arrow). E: Needle placement in the left side (Fluoroscopy image); F: Post-
ablation MRI (True FISP), showing the ablated area in the left side (red arrow); G: Necropsy image 
showing the ablated area in the left side (yellow arrow). 
A 
B C D 
E F G 
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Graphic 6 – Impedance and Power Measurements over Time in the treatment of the right side for pig #9. 
 
In MRI analysis the ablation area in the left side appeared much more defined with a 
semicircular shape (diameter ~2 cm). In the right side,  the ablation region was not as well defined 
and the heat appeared to have spread around a larger area (diameter ~4 cm).  The necropsy images 
revealed that the ablation area in the right side was smaller (2.5 cm) than the one in the left side (3 
cm) and the tissue in the left side appeared much more damaged in the ablation site that the right 
one. Furthermore necropsy images revealed that the heat spread more in the right side to the 
adjacent tissue (figure 24). 
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4.2.1.3 Treatment of pig #6 
 
In the treatment of pig #6, a lower value for the starting power was chosen (1 W) and the 
values were kept under 2 W for the rest of the treatment. To treat the left side, the initial power was 
set to 2 W for the first minute and the kept at 1 W, due to the high impedances and therefore the 
system does not allow to the user to increase the power. The treatment was stopped at 5 minutes and 
45 seconds and the probe was repositioned (graphic 7). The power was set to 2 W and treatment 
was stopped at 2 minutes and 30 seconds, since the both power and impedance were varying 
rapidly. 
A 
E 
F G 
Figure 24 – A: MR image (True FISP) used for treatment planning in the right (white arrow) and the left 
(blue arrow) sides. B: Needle placement in the right side (Fluoroscopy image); C: Post-ablation MRI (True 
FISP), showing the ablated area in the right side (green arrow); D: Necropsy image showing the ablated 
area in the right side (purple arrow). E: Needle placement in the left side (Fluoroscopy image); F: Post-
ablation MRI (True FISP), showing the ablated area in the left side (red arrow); G: Necropsy image 
showing the ablated area in the left side (yellow arrow). 
B C D 
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Graphic 7 – Impedance and Power Measurements over Time in the treatment of right and left sides for pig #6. 
 
The MRI analysis revealed a circle-shaped ablated area in the right side with 2 cm of 
diameter.  The ablated areas in the left side were very superficial in the lung and since the anterior 
part was full of fluid and adhesions they were difficult to visualize in the MR images. The ablated 
areas were overlapping (2 circle-shaped regions with very high intensity in the T2-w sequence) and 
the total ablated area was approximately 1.2 by 1.2 cm
2
. During the necropsy, it was possible to 
observe all the ablated areas, although in the right side only a superficial burning was clear and 
therefore it is possible that the ablation was performed deeper in the tissue. In the left side, two 
small ablated areas were perfectly seen with a measured size superior with the one obtained in MRI 
(2 by 1 cm
2
) (figure 25). However, around the main ablated areas, some of adjacent tissue appeared 
also to be damaged, since some heat might have spread. In the MRI it was also possible to observe 
that the lungs were collapsed after the treatment. 
0
0,5
1
1,5
2
2,5
0
100
200
300
400
500
600
700
0 50 100 150 200 250 300
Im
p
e
d
an
ce
 (
Ω
)
Time (s)
Impedance and Power Measurements over Time in the treatment of right 
and left sides
Impedance: ablation of the right 
side
Impedance: ablation of the left 
side
Power: ablation of the right side
Power: ablation of the left side
Cytoreductive Surgical Treatment of Pleural Mesothelioma 
42 
 
 
Figure 25– A: MR image (True FISP) used for treatment planning in the right (white arrow) and the left (blue 
arrow) sides. B: Needle placement in the right side (Fluoroscopy image); C: Post-ablation MRI (True FISP), 
showing the ablated area in the right side (green arrow); D: Necropsy image showing the ablated area in the 
right side (purple arrow). E: Needle placement in the left side (Fluoroscopy image); F: Post-ablation MRI 
(True FISP), showing the ablated area in the left side (red arrow); G: Necropsy image showing the ablated 
area in the left side (yellow arrow). 
 
 
4.2.1.4 Treatment of pig#3 
 
 
In the treatment of animal #3, the starting power was set to 5 W during the first minute to 
ablate both sides (one spot in the right side and two in the left side) of pleura. The power was 
increased in a rate of 2W/min until it reached the 15 W that was kept for 1 minute and then the 
treatment was stopped. The roll-off didn’t occur in any of the treatments since the impedance 
decreased over time, instead of increasing (graphic 8).  
A 
B C D 
E F G 
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Graphic 8 – Impedance and Power Measurements over Time in the treatment of right and left sides for pig #3. 
 
In the MR images of pig #3 acquired after RFA, the ablated areas appeared with no defined 
shape, in a total area of 2.6 by 1.6 cm
2
 in the right side and 1.7 by 2.3 cm
2
 in the left side of thoracic 
cavity where it was not possible to distinguish two ablation spots. In the necropsy images, however, 
the size measured for the ablated areas was superior both around 3 cm in diameter. The tissue 
seemed more damaged in the left side, but nevertheless only one ablation was observed (figure 26). 
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Figure 26 – A: MR image (True FISP) used for treatment planning in the right (white arrow) and the left 
(blue arrow) sides. B: Needle placement in the right side (Fluoroscopy image); C: Post-ablation MRI 
(True FISP), showing the ablated area in the right side (green arrow); D: Necropsy image showing the 
ablated area in the right side (purple arrow). E: Needle placement in the left side (Fluoroscopy image); F: 
Post-ablation MRI (TrueFISP), showing the ablated area in the left side (red arrow); G: Necropsy image 
showing the ablated area in the left side (yellow arrow). 
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4.2.1.5 Treatment of pig #7 
 
The last pig being treated with RFA, pig #7, was ablated once in the right side and twice in 
the left side. In the right side, the initial power was set to 5 W for 1 minute. The treatment was re-
initiated at 2 W, also for one minute, but the impedance increased to over 600 Ω and treatment was 
stopped. To ablate the left side, the power was set to 5 W (during one minute); 7 W (during one 
minute) and 3 W (kept one minute and increased at a rate of 2 W/minute until 7 W was reached 
again). The probe was repositioned for the second ablation of the left side and 5 W were applied in 
the first minute. However, the impedance increase to approximately 700 Ω and the power decreased 
to 1 W before the first minute was completed. A second attempt was completed at 2 W during 1 
minute (impedance = 220 Ω).  
In the MRI analysis after the treatment, two distinguishable ablated areas were observed in 
the left side. The ablated spot located more superiorly had an area of 1.5 by 2.6 cm
2
, while the 
second ablation spot had a size around 1.3 by 2.7 cm
2
. In the right side, an ablation area was also 
observed with a larger size than the ablated areas in the left side (diameter around 4 cm). All the 
ablated areas were located in more posterior slices comparatively with the other pigs. Through the 
evaluation of necropsy images, ablated areas did not appear to have a consistent shape with the 
electrode needle and they were located more posterior comparatively with the other pigs. Two 
ablated regions were observed in the left lung. In the right lung, ablated area appeared also to be in 
the posterior surface of the middle lobe. In the MRI it was also possible to observe that the lungs 
were collapsed. 
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Table 5 summarizes the powers applied during the pleural treatments, as well as the size of 
the ablated areas observed in MRI. 
Animal # Ablation Area Power/Time (Ws
-1
) Ablation size 
3 
Left Side of Pleural Space 1.00 2.3 by 1.7 cm
2
 
Right Side of Pleural Space 2.12 2.6 by 1.6 cm
2
 
4 
Left Side of Pleural Space 1.31 1.9 cm diameter 
Right Side of Pleural Space 1.51 2 cm diameter 
6 
Left Side of Pleural Space 0.11 2 cm diameter 
Right Side of Pleural Space 0.10 1.4 by 1.2 cm
2 
7 
Left Side of Pleural Space 
Left Side of Pleural Space (probe repositioned) 
1.06 
0.23 
1.5 by 2.5 cm
2 
1.3 by 2.7 cm
2 
Right Side of Pleural Space 0.34 4 cm diameter 
9 
Left Side of Pleural Space 4.82 2.3 cm diameter 
Right Side of Pleural Space 1.98 4 cm diameter 
Figure 27– A: MR Needle placement in the right side (Fluoroscopy image); B: Post-ablation MRI (True 
FISP), showing the ablated area in the right side (green arrow); D: Necropsy image showing the ablated area 
in the right side(purple arrow). E: Needle placement in the left side in the 1
st
 and 2
nd
 positioning of the probe 
(Fluoroscopy image); F: Post-ablation MRI (True FISP), showing the ablated areas in the left side (red and 
blue arrows); G: Necropsy image showing the ablated areas in the left side (yellow and white arrow). 
A B C 
E 
F 
D 
G 
Table 5 – Summary of the power applied in the pleural treatments and correspondent ablation size. 
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4.2.2 Liver treatment 
 
Treatments in the liver allowed to set and to maintain the power of the generator at higher 
loads than for the pleura. 
4.2.2.1. Treatment of pig #4 
 
For pig #4, the power was initially set to 30 W for the first minute. First roll-off occurred 
during the second minute of treatment; after the power was increased to 40 W. Treatment was 
restarted at 15 W for 5 minutes. However, the second roll-off occurred before this time period 
(power = 3 W; impedance = 500 Ω) and the treatment was stopped. Post-RFA MR images showed a 
semicircular ablation area with a diameter of approximately 2.6 cm. During the necropsy, a clear 
semi-circular ablation spot (diameter = 2.5cm) was observed showing good correlation with MR 
findings. However, the ablation spot was located 8 cm inferior comparatively with the position 
initially chosen for the ablation area (figure 28). 
 
 
 
 
 
 
 
 
Power/Time (Ws
-1
) = 1.51 
DP/A (mm) = 18.2 
 
Power/Time (Ws
-1
) = 1.51 
DP/A (mm) = 18.2 
A B C D 
Figure 28 – A: MR image (TWIST 4D) used for treatment planning in the liver (white arrow) B: Needle 
placement in the liver (Fluoroscopy image); C: Post-ablation MRI (True FISP), showing the ablated area 
in the liver (green arrow); D: Necropsy image showing the ablated area in the liver (purple arrow).  
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4.2.2.2. Treatment of pig #9 
 
Treatment of pig # 9 was initiated with a 30 W power form one minute and increased at a 
rate of 10 W/minute. First roll-off occurred before completing the third minute of treatment 
(impedance = 457 Ω). The treatment was restarted after a 30 second pause at 35% of the roll-off 
power, but second roll-off took place before completing 2 minutes. After the second roll-off power 
was set to 15 W and kept with this power for 5 minutes, with an impedance of 46 W. The power 
was increased at a rate of 10 W/minute until 45 W, after which the treatment was concluded 
(graphic 9). 
 
 
Graphic 9 – Impedance and Power Measurements over Time in the treatment of the liver for pig #9. 
 
 
The MRI analysis of pig #9 revealed an ablation area of 2.6 by 2.9 cm
2
, in the lower part of 
the right lobe of the liver. Necropsy findings were consistent with the results from MRI analysis, 
revealing an ablated spot with tissue more damaged in the center than in the periphery with 
approximately 3 by 2.5 cm
2
 (figure 29). Nevertheless comparing with the planned ablation area, the 
ablation spot was located 14 cm below the initial positioning of the probe. 
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4.2.2.3. Treatment of pig #6 
 
For the treatment of pig #6, in the liver, only 2 pads were used. The treatment was initiated 
with a 30 W power and increased at a 10 W/minute rate until achieve the 60 W. This power was 
maintained for 10 minutes, with an average impedance of 36 Ω, without rolling-off. In MRI and 
necropsy only a small ablation spot was observed posterior to the gallbladder (figure 30). The 
ablated area was therefore dislocated in 4 cm to the right side. 
 
 
4.2.2.4. Treatment of pig #3 
 
4.2.2.4. Treatment of pig #3 
 
Pig #3 was ablated in two regions of the liver. The starting power for the first ablation was 
30 W during one minute then increased for 40 W (impedance = 56 Ω). However, roll-off occurred 
Figure 29 – A: MR image (VIBE) used for treatment planning in the liver (white arrow) B: Needle 
placement in the liver (Fluoroscopy image); C: Post-ablation MRI (True FISP), showing the ablated area 
in the liver (green arrow); D: Necropsy image showing the ablated area in the liver (purple arrow).  
Figure 30 – A: MR image (TWIST 4D) used for treatment planning in the liver (white arrow) B: Needle 
placement in the liver (Fluoroscopy image); C: Post-ablation MRI (True FISP), showing a very small 
ablated area near the gallbladder in (green arrow); D: Necropsy image showing the ablated area in the liver 
(purple arrow). Probably, during the treatment probe was moved into the gallbladder.  
A B C D 
A B C D 
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before the second minute of treatment was completed The treatment was restarted at 20 W for 5 
minutes, but during this period power progressively decreased to 3 W (final impedance = 306 Ω). 
The probe was repositioned in the liver and the second treatment was also initiated with 30 W in the 
first minute, then increased to 40 W, after which the roll-off occurred (power = 5 W; impedance = 
435 Ω). The treatment restarted at 20 W (impedance = 45 Ω). After two minutes, the power starting 
to decreased until 3 W (impedance = 361Ω) and the treatment was ended. Post-RFA image analysis 
revealed two no-overlapped ablated areas with a circular shape with 3 cm and 2.5 cm in diameter. 
During necropsy, two ablated areas in the liver were clearly identified, being the tissue more 
damaged in the center of the ablation and decreasing the degree of ablation in the periphery. The 
ablation areas had 2.5-3.5 cm of diameter and correlated well with MR images features (figure 31). 
In the case of pig #3, the treatment areas were located accordingly with the treatment planning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 – A: MR image (TWIST 4D) used for treatment planning in the liver (white arrow); B and D: 
Needle placement in both target areas (Fluoroscopy image); C and E: Post-ablation MRI (True FISP), 
showing the resultant two ablated areas (green and yellow arrows); F: Necropsy image showing two 
ablated area in the liver (purple and red arrows).  
A 
B C 
D E 
F 
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4.2.2.5. Treatment of pig #7 
 
Ablation of pig #7 was initiated with 30 W for one minute, being the power increased to 40 
W in the second minute, when the treatment was interrupted. The ablation was restarted with a 20 
W power. After 3 minutes the power had decreased to 16 W but the treatment was not interrupted 
until 5 minutes were completed. The last treatment started with a 25 W power (graphic 10).  
 
 
Graphic 10 – Impedance and Power Measurements over Time in the treatment of the liver for pig #7. 
 
MRI analysis after radiofrequency ablation showed an ablation spot with an area of 3.3 by 
2.4 cm
2
. In the necropsy image, an ablated area with 2.5 cm of diameter (circular shape) was 
observed in the posterior surface of the liver, as seen in the MRI. Consistently with the results of the 
majority of the pigs, the tissue seemed more damaged in the center of the ablation spot with a 
decrease in tissue burning in the periphery (figure 32). The ablated area was located where it was 
initially planned for the treatment. 
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Table 6 summarizes the powers applied during the liver treatments, as well as the size of 
ablated areas observed in MRI. 
Animal # Ablation Area Power/Time (Ws
-1
) Ablation size 
3 
Liver (right upper lobe) 
Liver (right bottom lobe) 
5.45 
1.78 
3 cm in diameter 
2.5 cm diameter 
4 Liver (right lobe) 1.17 2.6 cm diameter 
6 Liver (right lobe) 2.033 1 cm diameter 
7 Liver (right lobe) 4.28 3.3 by 2.4 cm
2
 
9 Liver (right lobe) 6.45 2.6 by 2.9 cm
2
 
Figure 32 – A: MR image (VIBE, transversal) used for treatment planning in the liver (white arrow) B: 
Needle placement in the liver (Fluoroscopy image); C: Post-ablation MRI (True FISP), showing a very 
large ablated area in the liver (green arrow); D: Necropsy image showing a large ablated area in the liver 
(purple arrow).  
Table 6 – Summary of the power applied in the liver treatments and correspondent ablation size. 
A B C D 
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4.3 Magnetic Resonance-guided Focused Ultrasound Surgery 
 
The results of pleural and liver treatments are divided in two sub-sections and the results 
from each pig’s treatment are briefly described. 
 
4.3.1 Pleura treatment 
 
Since there were no references for this type of ablation (in pleural tissue) using MRgFUS, 
an escalation study was performed to determine the best dose to be used. 
 
4.3.1.1  Treatment of pig #8 
 
The first animal to be treated, pig #8, received the lowest acoustic energy in seven focal 
spots. For first five spots a direct hit approach was used and the beam was not angulated, since the 
area to be ablated was localized between the ribs. For the last two focal spots, nevertheless, 
ultrasound beam was angulated (32º) to pass closer to the bottom of the last rib. In MR subtraction 
images, it was possible to observe a small ablation spot in the right lung, near the heart, in the 
middle lobe of the left lung, with an area of approximately 1.5 by 1.3 cm
2
. During the necropsy, the 
corresponding ablation spot observed in the lung was very superficial. This ablated area was 
elongated (approximately 2.5 cm is height and less than 1 cm in weight), which was a larger area 
than the one expected from the results with MRI (figure 33).  
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4.3.1.2 Treatment of pig #10 
 
Pig #10 was ablated in only in 3 focal spots since area to be treated had smaller size. Each 
focal spot received an acoustic energy of 3912 J and after complete area had been ablated, the 
process was repeated with the same acoustic energy in the same focal spots. The beam was 
angulated between 7º and 21º to avoid being absorbed by the ribs. MRI analysis revealed a small 
ablated area of approximately 1.4 by 1.4 cm
2
, near the heart, in the lower lobe of the left lung. The 
necropsy analysis revealed a small and localized ablates region (diameter inferior to 1 cm) in the 
anterior part of the left lung. The size of the ablation spot in the necropsy was inferior to the size 
measured in the MRI (figure 34). 
 
 
Figure 33 – A: MR image (FIESTA) used for treatment planning in the pleura (white arrow) B: Post-
ablation MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area 
near the heart (green arrow); C: Necropsy image showing the ablated area in the pleura (purple arrow).  
A B C 
Figure 34 – A: MR image (FIESTA) used for treatment planning in the pleura (white arrow) B: Post-
ablation MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area 
near the heart (green arrow); C: Necropsy image showing the ablated area in the pleura (purple arrow).  
A B C 
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4.3.1.3 Treatment of pig #12 
 
For the treatment of pig #12, time was increased in 42% then rising the acoustic energy in 
the 5 focal spots chosen for the ablation. Ultrasound beam was angulated 32º.  Through the analysis 
of the MR images after the procedure, an ablation spot of 2.4 by 1.6 cm
2 
was measured in the lower 
lobe of the right lung, near the last rib. In the necropsy images an elongated ablation area was 
observed with an area of approximately 3 by 1.5 cm
2
 in the lower lobe of the right lung. Although 
the position was consistent with MRI findings, the size of the ablation spot was superior to that 
measured in the MR images (figure 35). 
 
 
 
 
4.3.1.4 Treatment of pig #13 
 
Pig #13 received the largest amount of acoustic energy. Every focal spot was also sonicated 
twice, but unlike pig #10, the first sonication was immediately followed by the second one for each 
spot, in order to avoid cooling before the second sonication. The ablation area was very close to the 
diaphragm and therefore some problems with motion were expected. Furthermore, during the 
ablation of 4
th
 focal spot, some reflection from the ribs was experienced and power was decreased 
to 300 W. The beam was kept angulated between 24º and 30º. In MRI, a 4.2 cm ablation region was 
Figure 35 – A: MR image (Localizer) used for treatment planning in the pleura (white arrow) B: Post-
ablation MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area 
near the diaphragm (green arrow); C: Necropsy image showing the ablated area in the pleura (purple 
arrow).  
A B C 
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observed in the right side of the diaphragm. The ablation area extended to the right lung, lower lobe 
for approximately 2.5 cm.  Necropsy of pig #13 permitted to observe a burn in the diaphragm, as 
well as the ablation area in the middle lobe of the right lung, consistent with the MRI analysis 
(figure 36). 
 
 
 
 
Table 7 summarizes the values of power and acoustic energy for the MRgFUS treatments 
applied during the pleura treatments, as well as the size of ablated areas observed in MRI. 
 
 
 
Animal 
# 
Number 
of focal spots 
Power 
(W) 
Duration (s) 
Energy 
(J) 
Focal Height (cm) Ablation size 
8 
3 
4 
200 
328 
20 
12 
4000 
3936 
~15.22 
~15.22 
1.5 by 1.3 cm
2
 
10 
3 (twice 
each spot) 
326 12 3912 ~11.71 1.4 by 1.4 cm
2
 
12 
5 (twice 
each spot) 
328 21 6888 ~12.85 2.4 by 1.6 cm
2
 
13 
7 (twice 
each focal 
spot) 
328 20 6560 
Between 12.85 and 
13.25 
4.2 by 2.5 cm
2
 
Figure 36 – A: MR image (FIESTA) used for treatment planning in the pleura (white arrow) B: Post-
ablation MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area 
near the diaphragm (green arrow); C: Necropsy image showing the ablated area in the pleura, in the 
diaphragm (purple arrow) and in the surface of the lung (yellow arrow).  
Table 7 – Summary of the different parameters of the MRgFUS treatments in the liver and correspondent 
ablation sizes (Values of power, duration and energy parameters correspond to each focal spot). 
A B C 
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Skin burns were observed in both pigs #12 and #13. These two pigs received the highest 
acoustic energy (figure 25). In pig #10, burns were observed not in skin, but in the muscle between 
the sternum and the skin (4 by 4 cm
2
) (figure 37). 
 
 
4.3.2 Liver treatment 
 
4.3.2.1 Treatment of pig #8 
 
For the treatment of pig #8 in the liver, 5 focal spots were chosen near the diaphragm and 
each one received 3936 J of acoustic energy with a beam angle of 32º. The total average 
temperature applied in the liver was 50.87 ºC (standard deviation of 2.27 ºC). Post-ablation MRI 
revealed a small ablated area of 1.1 by 0.7 cm
2 
in the lower part of the right lobe. Necropsy showed 
a small ablated region (0.5 by 0.5 cm
2
); this ablation spot was located more inferior than what had 
been initially planned (figure 38).  A white area on the surface of the upper right part of the liver 
may indicate tumor since it was the region where the mesothelioma cells were inoculated. 
Nevertheless the ablated area obtained with MRgFUS was located further below that region. 
Figure 37 – Burns were observed in 3 of the 4 pigs treated with MRgFUS. Left: pig # 10 revealed a burn 
in the muscle between  skin and sternum; Middle: skin burn of pig #12; Left: skin burn of pig #13. 
A B C 
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4.3.2.2 Treatment of pig #10 
 
In the case of pig #10, as aforementioned for the pleura, tissue was ablated in 5 focal spots 
and after the first cycle of 5 sonications, the process was repeated a second time, with an acoustic 
energy of 3912 J per sonication and a 4º ultrasound beam. The temperature values provided by the 
thermometry software were very high, with a large standard deviation and therefore they were 
considered incorrect. The MRI analysis post-ablation revealed a small ablated area of 0.7 by 0.7 
cm
2
 in the upper middle region of the liver. However, no ablated region was observed during the 
necropsy, which might be correlated with the fact that the ablation was deeper in the tissue, also due 
its small size it was more difficult to observe it during tissue collection. 
Figure 38 – A: MR image (VIBE) used for treatment planning in the liver (white arrow) B: Post-ablation 
MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area far below 
the target area (green arrow); C: Necropsy image showing the ablated area in the liver (purple arrow).  
B A C 
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2.3.2.4 Treatment of pig #12 
 
Treatment of pig #12 also in the liver was also performed with 5 sonications spots, but 
acoustic energy was increased to 6909 J and a 32º angle for the ultrasound beam. The total average 
temperature applied in the liver was 53.72 ºC (standard deviation of 3.54 ºC). The MRI results 
revealed an ablated area of 2.4 by 1.6 cm
2
 in the lower part of the right lobe. During necropsy, an 
ablated region from the MRgFUS treatment was observed in the lower part of the left lobe as 
expected from the treatment planning. This ablation spot had an area of 1.5 by 1.5 cm
2
 and a depth 
of 1.2 cm which it was slightly inferior size when compared to MRI (figure 40). Tissue appeared 
more damaged in the center of the ablation area and heat seemed to have spread only to a small 
region in the periphery of the ablation area.  
Figure 39 – A: MR image (VIBE) used for treatment planning in the liver (white arrow) B: Post-ablation 
MRI (subtraction of LAVA images before and after ablation), showing a very small ablated area near the 
diaphragm (green arrow); during necropsy, no ablated area was observed.  
A B 
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2.3.2.4 Treatment of pig #13 
 
Pig #13, similarly to the procedure in the pleura, received two consecutive sonications in 
each focal spot, in a total of 5 spots. Each sonication had an acoustic energy of 6560 J and the beam 
was angles 17.5º. The total average temperature applied in the liver was 62.83 ºC (standard 
deviation of 4.69 ºC). The increase in the energy resulted in the largest ablation area of this study 
measured in both MR images and during the necropsy. Post-ablation MRI results revealed a 
ablation area of 2.3 by 2.1 cm
2
. The ablation area was seen during necropsy in the lower part of the 
left lobe, which corresponded to the planned location for the treatment and also to the location of 
the ablation area verified in the post-ablation MRI (figure 41). This ablated region had an area of 3 
by 1.8 cm
2
 and a depth of 1.5 cm and it was similar to pig’s #12 ablation spot with the tissue in the 
center of the ablation spot more severely burned comparatively to the periphery. 
 
A B C 
Figure 40 – A: MR image (VIBE) used for treatment planning in the liver (white arrow) B: Post-ablation 
MRI (subtraction of LAVA images before and after ablation), showing a large ablated area correspondent 
to the target area (green arrow); C: Necropsy image showing the ablated area in the liver (purple arrow).  
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Table 8 summarizes the values of power and acoustic energy for the MRgFUS treatments 
applied during the liver treatments, as well as the size of the ablated areas observed in MRI. 
 
 
  
Animal # 
Number of 
focal spots 
Power (W)  Duration (s) Energy (J) 
Focal 
Height (cm) 
Ablation 
Size 
8 5 328 12 3936 ~13.70 
0.5 by 0.5 
cm
2
 
10 
5 (twice each 
spot) 
326 12 3912 ~11.71 
0.7 by 0.7 
cm
2
 
12 5  329 21 6909 ~11.55 
2.4 by 1.6 
cm
2
 
13 5 328 20 6560 ~11.10 
2.3 by 2.1 
cm
2
 
Table 8 – Summary of the different parameters of the MRgFUS treatments in the liver and correspondent 
ablation sizes (Values of power, duration and energy parameters correspond to each focal spot). 
Figure 41 – A: MR image (VIBE) used for treatment planning in the liver (white arrow) B: Post-ablation 
MRI (subtraction of LAVA images before and after ablation), showing a large ablated area correspondent 
to the target area (green arrow); C: Necropsy image showing the ablated area in the liver (purple arrow).  
A B C 
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CHAPTER V 
Discussion 
 
Tumor model was successfully developed in the pleura, with predominant presence of 
adhesions in all pigs. However, no large tumor masses were detected, probably due to the early 
stage of tumor development at the final time point. The number of cells used for this study was 
based on a reference cell number used in the induction of mesothelioma in nude mice. Nevertheless, 
pigs were not genetically immunosuppressed and their size was much bigger than the mice, so even 
with cell number adjustment the tumor development was expected to be slower. Furthermore, 
adhesions were not strictly localized in the right lower hemithorax where cells were inoculated, but 
as expected spread for the entire thoracic cavity. This feature might be related with the 
aggressiveness of the cell line plus fact that cells were suspended in a solution which contributes for 
their high mobility. A matrigel-based medium could have increased the probability of maintaining 
them more restricted to a specific region of the pleura and therefore, increasing the probability for 
the development of more localized masses. MSTO-211H cells, however, are characterized by their 
high mobility which is a reinforcement factor for the adhesion extension through the entire thoracic 
cavity.   
In all pigs diaphragm showed an increase in thickness, as well as in the pericardium. With 
the resolution of MR imaging it was difficult to distinguish the membrane from the pericardial fluid. 
Studies indicate that pericardium generally increases with heart size and in pigs the average 
thickness is around 0.2 mm [27]. The values obtained for these pigs are much superior to this 
reference value. It is probable that in our quantification the pericardium fluid was also measured 
instead of pericardium itself. When comparing the pericardium and the heart development both 
structures increased their sizes at the same rate and therefore the increase in pericardium thickness 
was considered as part of the normal growth of the animals that kept gaining weight through the 
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weeks. The diaphragm thickness however increased in the first 8 weeks after inoculation, then 
reaching a plateau. One might assume that this rise in the thickness is due to the disease model since 
the increase in the number of adhesions limited the movement of the lungs, which implies that the 
diaphragm needed to increase their work to compensate and guarantee the respiratory motion 
necessary for the pig to breathe.  
Treatments in the liver were based on MR images since some hyperintensity regions 
appeared in the T2-weighted images.  The fact that MSTO-211 H cell line has high migratory rates 
might have compromised the cell agglomeration and as they spread through the liver and do not 
form spatially localized masses such as in the case of hepatocellular carcinoma. The hyperintensity 
regions in T2-w images may also indicate areas with differences in blood flow, due to the high 
quantity of blood supply in the liver. After necropsy no macroscopic tumors were observed, except 
on pig #8.  
The two animals that died after the inoculation procedure didn’t show any significant signs 
of pulmonary or liver disease and therefore their death was not associated with any previous 
condition. No necropsy or post-MRI were performed but one hypothesis is that during inoculation 
of the liver one of the major blood vessels might have been ruptured causing internal bleeding that 
ultimately resulted in animals death. 
Two initial control animals (pigs#1 and #2) received only half dose of cyclosporine 
comparatively to the other pigs since it was the dose recommended for humans that get organ 
transplant. However, pigs do not have the same predisposition to cyclosporine as humans. Frey et 
al. [28] proved that the blood concentrations of Cyclosporin were consistently lower in pigs that in 
patients when administered both orally and iv, which means that for transplant or other procedures 
requiring immunosuppression in pigs it is advisable to increase the dosage. Furthermore, in the first 
follow-up of pigs #1 and #2 no signs of disease were observed and therefore cyclosporine dose was 
increased for the rest of the pigs. Cyclosporine administration was not maintained until the 
treatment of the animals for financial reasons as well as for a drug shortage and was stopped at 
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different time points. Animals showed no regression in tumor growth after being withdraw from 
cyclosporine. Consequently, we conclude that cyclosporine administration is needed to induce the 
tumor but its administration is not necessary to continue the entire tumor development. We were 
able to induce tumors in pigs receiving cyclosporine only for 4 weeks.  
Through the analysis of tables 1 (number of cells injected) and 4 (severity of disease), it is 
possible to conclude that animals that received a number superior to 6x10
^6
 cells showed more 
severe signs of the disease. However, between animals that received a number of cells superior to 
6x10
^6
 no significant correlation was found between the number of cells and the severity of the 
disease. 
Several MR pulse sequences were used in the follow-ups of the animals to investigate 
tumor signs, most of them T2-weighted. True FISP sequences revealed to be very sensitive to both 
fluid and pleural and diaphragm thickening due to the increase in signal intensity in these regions. 
VIBE sequence also showed good results and resolution for the detection of adhesions. Despite 
being mechanically ventilated and breath-holds were performed during the image acquisition, 
motion artifacts were frequently observed being difficult to use the images for quantification of 
tissue thickening.  The TWIST and VIBE sequences used in the protocol were very helpful for 
detecting blood flow alterations in the liver. HASTE and Blade T2-w did not present very high 
resolution being very difficult to distinguish some of the structures important to characterize the 
disease, such as the pericardium and the diaphragm, and therefore these sequences were not used in 
any quantification or treatment planning.  
Through the analysis of the results of the Radiofrequency Ablation treatments, it was 
possible to conclude the feasibility of the technique in both pleura and liver. In the pleura, the 
values set for the power were decreased for the last treatments due to difficulty in maintaining the 
powers recommended by the probe manufacturer. However, the equipment was designed to be a 
single use electrode for the treatment of liver tumor. This organ is much more irrigated than the 
pleura and the lungs and so the heat generated during the liver treatment was dissipated rapidly. An 
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advantage of using an ‘umbrella’ type RFA probe is that its configuration improves the contact 
between the electrode and the tissue which allowed the probe to move along with the lungs, 
avoiding a great misplacement of the ablated area comparatively with the planned treatment. This 
feature was very advantageous in the treatment of pleura where most of the ablation areas where 
placed in the planned ablation area, particularly with the presence of adhesions. However, for the 
liver treatment, probably due to different nature of the tissue, probe didn’t have such a good contact 
with the tissue. Therefore the distance between the target and the resultant ablation after the 
treatment ranged between 4 cm and 14 cm. One disadvantage with this RFA probe was the MRI-
compatibility. Therefore, despite using MRI to plan the treatment, the guidance was performed 
using fluoroscopy imaging. Nevertheless the probe was positioned approximately at the matching 
the location in the MRI where adhesions and fluid had been previously observed. For this pilot 
study and due to the spread of the disease, this factor did not compromise the research, but in future 
studies it would be convenient to use MR-compatible equipment or use CT-guided RFA. 
Although the initial objective was treating tumor masses in the pleura, the early stage of 
tumor development in all animals was mostly characterized with adhesions, and therefore the 
treatment was planned in order to «break» the adhesions so RFA could become an alternative to 
P/D and EPP. Nevertheless, the probe was inserted deeper in tissue reaching the surface of the lungs 
where all the ablated areas were observed. When comparing the ablated regions between right and 
left side, in most cases the ablation area is larger and more defined in the right side of thoracic 
cavity where the inoculation took place. This was expected since the roll-off occurred sooner during 
the treatment of left side and hence the power delivered was inferior. This might have occurred 
since after treating the right side, the heat spread for the thoracic cavity and when ablating the left 
side the feedback of the thermocouples in the ‘umbrella’ electrode was based in both the heat being 
generated at that time point and the remaining heat in the thoracic cavity from the previous 
treatment. When comparing the ablated regions obtained in the right and left side for each animal, it 
is possible to conclude that higher values for power/time permitted to obtain more damage in the 
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tissue. In some cases, such as during the ablation of the right side of pig #6, some tissue was over-
exposed to treatment. Therefore, one of the disadvantages when using this system in the pleura was 
to have a precise control for the impedance values. 
On the other hand, the algorithm suggested by the probe manufacturer was successfully 
followed for the treatment of the liver, which means that higher energy was applied comparatively 
with the pleura. The size of the ablation spots was around 2.5 cm in diameter and they were 
consistently defined with a circle-shape as expected when using this type of electrode. However the 
contact between the electrode and the tissue was more difficult and the location of the ablation areas 
were different from those planned. In pig #6 only a small liver ablation spot was observed due to 
close proximity with the gallbladder.  
MRgFUS has not been used to successfully treat lung cancer due to the high number of air-
tissue interfaces. The new approach used with mesothelioma model reduces the risk of the 
reflection of the focused ultrasound beam. Furthermore, in case of some reflection had occurred due 
to the deeper penetration of the beam in the tissue, in the specific case of mesothelioma, it would be 
benefic since most of the reflected heat would deposit in the pleura. Nevertheless the temperature 
values obtained by the software developed for uterine fibroids clinical treatment were not correct 
(average value was too high, as well as the standard deviation) and therefore this represents a 
challenge for the application of MRgFUS in mesothelioma using the commercially available 
equipment.  
MRgFUS proved to be an effective treatment tool for both mesothelioma and liver cancer 
models. It produced ablation areas with approximately the same size of the ones obtained with 
RFA, but it did not require any incisions. It implies, however, the application of a larger amount of 
acoustic energy which caused skin burns in the animals. To our knowledge MRgFUS had never 
been used for a mesothelioma swine model and therefore, for this first pilot study, the power and 
time were progressively increased to evaluate the size, depth and side effects of the high power 
sonications. For future studies, these values might be used as a reference and the acoustic energy 
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may be reduced in order to avoid skin burns. Another option is to increase the cooling timeand the 
overall treatment time. A new approach using acoustic reflector materials such as foam or cork 
placed in a near field underneath a gel phantom has been used to shield the skin from the ultrasound 
beam. The preliminary results showed that it was possible to avoid burns through the insertion of 
these materials, by increasing the sonications depth and decreasing the radius of the reflector. 
Therefore, it enables the possibility of sparing patients skin tissue while making only a few 
adjustments in the setup for the treatment.  
Although for each pig the dose applied in the pleura was the same used for the liver, 
treatment appeared to have more effectiveness in the liver. Ablation areas were perfectly seen when 
using higher energy values and their size also increased with energy, as expected since heat 
deposition is also superior. In pig #10, no ablation spot was observed in the liver during the 
necropsy, probably because focal spot was located deeper in tissue according to the MR images.  
MRgFUS has the advantage of using MRI that enables a more precise treatment planning 
since the location of the ablation spots can be verified prior to treatment. Furthermore, since the 
sonication time was comparatively lower than the RFA ablation time, it was possible to treat the 
animal under a breath-hold regimen then avoiding some of the artifacts related with organ motion. 
In the case of this study, the location of the ablated regions observed in the pleura after the 
treatment corresponded to the areas previously planned to be ablated. On the other hand, in the liver 
the locations of the ablations were systematically inferior to what was initially planned, probably 
due to acoustic reflection from the ribs. 
Overall, MRgFUS results showed ablated areas with similar sizes to those obtained with 
RFA and also permitted to define the shape of the ablation spot for more accurate treatments. 
Although the treatment planning requires more time during MRgFUS, the ablation area could 
verified prior to the treatment enabling the operator to ensure that the sonications were performed 
only in the targeted areas and therefore making MRgFUS a more precise technique. 
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Conclusion 
 
Malignant Pleural Mesothelioma is a severe condition, which is affecting an increasing 
number of people in the recent decades.  So far, the conventional therapy is not effective enough 
and the majority of the patients cannot tolerate the surgery that enables de reduction of the primary 
tumor, and chemotherapy and radiotherapy are not effective enough is these cases to completely 
remove the tumor.  
This study was an innovative project in both tumor characterization and treatment of MPM. 
First, we were able to successfully develop a tumor model in large animals using a human 
mesothelioma cell line. To our knowledge, this method was only applied in small animals and they 
generally died in the first 40 days. In large animals, more invasive methods were used to induce the 
disease and therefore, this study proved the feasibility of cell inoculation in mesothelioma 
development in large animals and furthermore it allowed to characterize the early stages of the 
disease before animals’ health deteriorate. 
This project was also the first one to apply RFA and MRgFUS in this type of disease (to our 
knowledge).  We were able to prove the feasibility of both techniques and we obtained ablations 
areas with approximately the same size. However, MRgFUS has the advantage of not requiring 
incisions and there are methods to avoid the skin burns. Furthermore, it is easier to ablate larger 
areas with MRgFUS, because with RFA probe needs to be inserted several times to obtain larger 
ablation areas, even with larger diameter probes. Since this was just a pilot study to investigate the 
feasibility of both techniques in the pleura, no histology was performed to characterize the ablation 
areas tissue for all pigs.  It would be interesting to further investigate the changes in the tissue with 
both therapies and compare the results with the power applied in each ablation area. 
Since this is a new area of research, this project allowed to study some of the parameters in 
MRgFUS to obtain a successful ablation in the pleura. Nevertheless, this topic requires more 
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research and, therefore, another study with a larger number of animals will be necessary for 
statistical significance.  
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